Chylous Ascites: A Rare Initial Presentation of Pancreatic Carcinoma

被引:5
作者
Ghafoor, Ammarah [1 ]
Hashmi, Junaid Zia [2 ]
Mateen, Abdul [3 ]
Hashmi, Qurat Ul Ain [3 ]
机构
[1] Nishtar Hosp, Dept Internal Med, Multan, Pakistan
[2] Nishtar Hosp, Dept Gen Surg, Multan, Pakistan
[3] Multan Inst Nucl Med & Radiol, Dept Radiat Oncol, Multan, Pakistan
来源
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2020年 / 30卷 / 09期
关键词
Chylous ascites; Triglyceride level; Pancreatic carcinoma;
D O I
10.29271/jcpsp.2020.09.989
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chylous ascites as first manifestation of pancreatic carcinoma is very rare. Usual presentations of pancreatic malignancy are abdominal discomfort, back pain, obstructive jaundice and duodenal obstruction. Development of chylous ascites during the course of the disease signifies poor prognosis. Malignancy and tuberculosis are the most common causes of this condition in developed and developing countries, respectively. Diagnosis is made on elevated triglyceride levels in ascitic fluid examination. Management is directed towards the treatment of primary cause and the chylous ascites. High protein and medium chain triglyceride diet is usually advised along with Orlistat for managing this condition. Peritoneovenus shunting can also be done but at the risk of complications. Our patient developed chylous ascites early in the course of the pancreatic carcinoma. CT scan abdomen was non-conclusive and cervical lymph node biopsy later on revealed that the primary disease was occult pancreatic carcinoma.
引用
收藏
页码:989 / 991
页数:3
相关论文
共 9 条
[1]   Chylous ascites: A collective review [J].
Aalami, OO ;
Allen, DB ;
Organ, CH .
SURGERY, 2000, 128 (05) :761-778
[2]  
Al-Busafi S A, 2014, ISRN HEPATOL, V2014, P240473
[3]   Lymphomas and chylous ascites: Review of the literature [J].
Almakdisi, T ;
Massoud, S ;
Makdisi, G .
ONCOLOGIST, 2005, 10 (08) :632-635
[4]   Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment [J].
Bhardwaj, Richa ;
Vaziri, Haleh ;
Gautam, Arun ;
Ballesteros, Enrique ;
Karimeddini, David ;
Wu, George Y. .
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2018, 6 (01) :105-113
[5]   ETIOLOGY AND TREATMENT OF CHYLOUS ASCITES [J].
BROWSE, NL ;
WILSON, NM ;
RUSSO, F ;
ALHASSAN, H ;
ALLEN, DR .
BRITISH JOURNAL OF SURGERY, 1992, 79 (11) :1145-1150
[6]  
Cárdenas A, 2002, AM J GASTROENTEROL, V97, P1896
[7]   Peritoneovenous shunting for intractable chylous ascites complicated with lymphangioleiomyomatosis [J].
Makino, Yuko ;
Shimanuki, Yuri ;
Fujiwara, Noriko ;
Morio, Yoshiteru ;
Sato, Koichi ;
Yoshimoto, Jiro ;
Gunji, Yoko ;
Suzuki, Tsutomu ;
Sasaki, Shin-ichi ;
Iwase, Akihiko ;
Kawasaki, Seiji ;
Takahashi, Kazuhisa ;
Seyama, Kuniaki .
INTERNAL MEDICINE, 2008, 47 (04) :281-285
[8]   Underlying etiology determines the outcome in atraumatic chylous ascites [J].
Mandavdhare, Harshal S. ;
Sharma, Vishal ;
Singh, Harjeet ;
Dutta, Usha .
INTRACTABLE & RARE DISEASES RESEARCH, 2018, 7 (03) :177-181
[9]   Establishment of triglyceride cut-off values to detect chylous ascites and pleural effusions [J].
Thaler, Markus A. ;
Bietenbeck, Andreas ;
Schulz, Christoph ;
Luppa, Peter B. .
CLINICAL BIOCHEMISTRY, 2017, 50 (03) :134-138